JP2015517535A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517535A5
JP2015517535A5 JP2015512969A JP2015512969A JP2015517535A5 JP 2015517535 A5 JP2015517535 A5 JP 2015517535A5 JP 2015512969 A JP2015512969 A JP 2015512969A JP 2015512969 A JP2015512969 A JP 2015512969A JP 2015517535 A5 JP2015517535 A5 JP 2015517535A5
Authority
JP
Japan
Prior art keywords
group
formula
compound
protecting group
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2015512969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517535A (ja
Filing date
Publication date
Priority claimed from AU2013204005A external-priority patent/AU2013204005B2/en
Application filed filed Critical
Publication of JP2015517535A publication Critical patent/JP2015517535A/ja
Publication of JP2015517535A5 publication Critical patent/JP2015517535A5/ja
Ceased legal-status Critical Current

Links

JP2015512969A 2012-05-23 2013-04-24 改善された合成 Ceased JP2015517535A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2012902119 2012-05-23
AU2012902119A AU2012902119A0 (en) 2012-05-23 Improved synthesis
AU2013204005 2013-04-11
AU2013204005A AU2013204005B2 (en) 2012-05-23 2013-04-11 Improved synthesis
PCT/AU2013/000416 WO2013173862A1 (en) 2012-05-23 2013-04-24 Improved synthesis

Publications (2)

Publication Number Publication Date
JP2015517535A JP2015517535A (ja) 2015-06-22
JP2015517535A5 true JP2015517535A5 (https=) 2016-07-14

Family

ID=49622929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512969A Ceased JP2015517535A (ja) 2012-05-23 2013-04-24 改善された合成

Country Status (13)

Country Link
US (1) US20150105543A1 (https=)
EP (1) EP2852607B1 (https=)
JP (1) JP2015517535A (https=)
CN (1) CN104395333B (https=)
AU (1) AU2013204005B2 (https=)
BR (1) BR112014029189A2 (https=)
CA (1) CA2874030A1 (https=)
EA (1) EA201492194A1 (https=)
HK (1) HK1202876A1 (https=)
IN (1) IN2014DN10846A (https=)
MX (1) MX356853B (https=)
TW (1) TWI609025B (https=)
WO (1) WO2013173862A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193858B (zh) * 2013-04-12 2016-08-03 中国海洋大学 螺甾碱烷型糖苷生物碱的合成方法
AU2018217439B2 (en) * 2017-02-10 2021-11-25 Oncology Research International Limited Steroid saponins with anti-cancer activity
CN110790811A (zh) * 2019-10-10 2020-02-14 华南农业大学 双相体系氯化铝水解制备薯蓣皂素方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115346C (zh) * 2000-10-20 2003-07-23 中国科学院上海有机化学研究所 鼠李糖取代的β-D-葡萄糖基-薯蓣皂甙的皂甙库、制备方法和用途
CN101130568B (zh) * 2007-09-07 2011-06-15 中国科学院上海有机化学研究所 一类喷脑皂甙类化合物、合成方法及其用途
JP5706815B2 (ja) * 2008-04-08 2015-04-22 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ トリテルペンであるサポニン、その合成法および使用
CN101635335B (zh) * 2008-07-25 2013-02-27 深圳市比克电池有限公司 圆柱电池卷芯入壳机

Similar Documents

Publication Publication Date Title
ES2662500T3 (es) El uso de esteroides de pregnano y androstano para la preparación de una composición farmacéutica para el tratamiento de trastornos del sistema nervioso central
JP6174575B2 (ja) ベラプロストの製造方法
JP7426412B2 (ja) カンナビジオール系化合物の製造方法
NO20085417L (no) Krystallinske former av 11beta-(4-acetylfenyl)-20,20,21,21,21-pentafluor-17-hydroksy-19-nor-17alfa-pregna-4,9-dien-3-on
HRP20201275T1 (hr) Kristalni oblik derivata benzimidazola i postupak njegove proizvodnje
EP4023641A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
JP2010510210A5 (https=)
BR112018006892B1 (pt) Composto, composição farmacêutica do mesmo e seus usos como moduladores do receptor farnesoide x
KR20180052756A (ko) 담즙산 유도체 제조를 위한 방법 및 중간체
JP2015517535A5 (https=)
CN103193858B (zh) 螺甾碱烷型糖苷生物碱的合成方法
KR20160051693A (ko) 이미다졸릴 프로게스테론 길항제
WO2009082846A1 (fr) Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
CN102649790B (zh) (13aS,14S)-14-氨基菲并吲哚里西啶生物碱衍生物以及它们的制备、抗植物病毒活性
CN105348365A (zh) 一种胆酸衍生物及其制备方法、药物组合物和用途
ES2565194T3 (es) Procedimiento para la preparación de 17-desoxi-corticosteroides
US20120309990A1 (en) Processes for the Purification of Lubiprostone
Tsepaeva et al. Reaction of Methyl (2-Methylidene)-3-oxolup-20 (29)-en-28-oate with Dimethyl Trimethylsilyl Phosphite
MX2014014056A (es) Sintesis mejorada.
CN104119414A (zh) 高质量黄体酮的制备方法
Chen et al. Stereoselective glycosylation of d-galactals by diethyl phosphorochloridite-and AlCl3-assisted Ferrier rearrangement
RU2566368C1 (ru) СПОСОБ ПОЛУЧЕНИЯ 6-МЕТИЛЕНО-16α,17α-ЦИКЛОГЕКСАНОПРЕГН-4-ЕН-3,20-ДИОНА
KR101821685B1 (ko) 베라프로스트 제조 중간체의 제조방법
CN107827948A (zh) 3β‑乙酰氧基‑17‑芳基雄甾‑5,16‑二烯
CN103122009A (zh) 两种用于合成他卡西醇支链的重要中间体化合物